Bioinformatics analysis and prediction of Alzheimer's disease and alcohol dependence based on Ferroptosis-related genes.

Mei Tian, Jing Shen, Zhiqiang Qi, Yu Feng, Peidi Fang
Author Information
  1. Mei Tian: The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Nanjing, China.
  2. Jing Shen: The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Nanjing, China.
  3. Zhiqiang Qi: The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Nanjing, China.
  4. Yu Feng: Medicine and Health, The University of New South Wales, Kensington, NSW, Australia.
  5. Peidi Fang: The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Nanjing, China.

Abstract

Background: Alzheimer's disease (AD) is a neurodegenerative disease whose origins have not been universally accepted. Numerous studies have demonstrated the relationship between AD and alcohol dependence; however, few studies have combined the origins of AD, alcohol dependence, and programmed cell death (PCD) to analyze the mechanistic relationship between the development of this pair of diseases. We demonstrated in previous studies the relationship between psychiatric disorders and PCD, and in the same concerning neurodegeneration-related AD, we found an interesting link with the Ferroptosis pathway. In the present study, we explored the bioinformatic interactions between AD, alcohol dependence, and Ferroptosis and tried to elucidate and predict the development of AD from this aspect.
Methods: We selected the Alzheimer's disease dataset GSE118553 and alcohol dependence dataset GSE44456 from the Gene Expression Omnibus (GEO) database. Ferroptosis-related genes were gathered through Gene Set Enrichment Analysis (GSEA), Kyoto Encyclopedia of Genes and Genomes (KEGG), and relevant literature, resulting in a total of 88 related genes. For the AD and alcohol dependence datasets, we conducted Limma analysis to identify differentially expressed genes (DEGs) and performed functional enrichment analysis on the intersection set. Furthermore, we used ferroptosis-related genes and the DEGs to perform machine learning crossover analysis, employing Least Absolute Shrinkage and Selection Operator (LASSO) regression to identify candidate immune-related central genes. This analysis was also used to construct protein-protein interaction networks (PPI) and artificial neural networks (ANN), as well as to plot receiver operating characteristic (ROC) curves for diagnosing AD and alcohol dependence. We analyzed immune cell infiltration to explore the role of immune cell dysregulation in AD. Subsequently, we conducted consensus clustering analysis of AD using three relevant candidate gene models and examined the immune microenvironment and functional pathways between different subgroups. Finally, we generated a network of gene-gene interactions and miRNA-gene interactions using Networkanalyst.
Results: The crossover of AD and alcohol dependence DEG contains 278 genes, and functional enrichment analysis showed that both AD and alcohol dependence were strongly correlated with Ferroptosis, and then crossed them with Ferroptosis-related genes to obtain seven genes. Three candidate genes were finally identified by machine learning to build a diagnostic prediction model. After validation by ANN and PPI analysis, ROC curves were plotted to assess the diagnostic value of AD and alcohol dependence. The results showed a high diagnostic value of the predictive model. In the immune infiltration analysis, functional metabolism and immune microenvironment of AD patients were significantly associated with Ferroptosis. Finally, analysis of target genes and miRNA-gene interaction networks showed that hsa-mir-34a-5p and has-mir-106b-5p could simultaneously regulate the expression of both CYBB and ACSL4.
Conclusion: We obtained a diagnostic prediction model with good effect by comprehensive analysis, and validation of ROC in AD and alcohol dependence data sets showed good diagnostic, predictive value for both AD (AUC 0. 75, CI 0.91-0.60), and alcohol dependence (AUC 0.81, CI 0.95-0.68). In the consensus clustering grouping, we identified variability in the metabolic and immune microenvironment between subgroups as a likely cause of the different prognosis, which was all related to Ferroptosis function. Finally, we discovered that hsa-mir-34a-5p and has-mir-106b-5p could simultaneously regulate the expression of both CYBB and ACSL4.

Keywords

References

  1. Alcohol. 2023 Mar;107:108-118 [PMID: 36155778]
  2. Alcohol Res. 2012;34(3):355-61 [PMID: 23134052]
  3. OMICS. 2012 May;16(5):284-7 [PMID: 22455463]
  4. Nucleic Acids Res. 2018 Jul 2;46(W1):W60-W64 [PMID: 29912392]
  5. Blood. 2023 Mar 2;141(9):1007-1022 [PMID: 36332160]
  6. Alcohol Res Health. 2008;31(4):377-88 [PMID: 23584011]
  7. Lancet. 2020 Aug 8;396(10248):413-446 [PMID: 32738937]
  8. J Pers Med. 2020 Sep 04;10(3): [PMID: 32899797]
  9. Mol Cancer. 2022 Aug 19;21(1):168 [PMID: 35986274]
  10. Neural Regen Res. 2023 Jun;18(6):1196-1202 [PMID: 36453394]
  11. Evid Based Ment Health. 2018 Feb;21(1):12-15 [PMID: 29273599]
  12. Nucleic Acids Res. 2019 Jul 2;47(W1):W234-W241 [PMID: 30931480]
  13. Cell Death Dis. 2020 Feb 3;11(2):88 [PMID: 32015325]
  14. Aging Cell. 2019 Feb;18(1):e12873 [PMID: 30488653]
  15. Addiction. 2020 Aug;115(8):1580-1589 [PMID: 32112474]
  16. Imeta. 2022 Jul 08;1(3):e36 [PMID: 38868713]
  17. Methods Mol Biol. 2018;1750:363-370 [PMID: 29512086]
  18. J Neuroinflammation. 2005 Oct 18;2:23 [PMID: 16232318]
  19. Front Mol Biosci. 2021 Dec 07;8:756085 [PMID: 34950700]
  20. Bioinformatics. 2010 Jun 15;26(12):1572-3 [PMID: 20427518]
  21. Front Oncol. 2019 Dec 10;9:1314 [PMID: 31921619]
  22. Front Aging Neurosci. 2021 Mar 15;13:641080 [PMID: 33790780]
  23. Neurochem Int. 2017 Mar;104:34-48 [PMID: 28082232]
  24. Nat Methods. 2015 May;12(5):453-7 [PMID: 25822800]
  25. Biomark Res. 2021 Jul 2;9(1):53 [PMID: 34229751]
  26. Pharmacol Ther. 2023 Apr;244:108373 [PMID: 36894028]
  27. Lancet Public Health. 2022 Feb;7(2):e105-e125 [PMID: 34998485]
  28. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5 [PMID: 23193258]
  29. Int Rev Neurobiol. 2014;118:359-80 [PMID: 25175869]
  30. Front Immunol. 2021 Jul 02;12:687975 [PMID: 34276676]
  31. BMC Bioinformatics. 2004 Aug 10;5:108 [PMID: 15304201]
  32. Environ Pollut. 2023 Aug 15;331(Pt 1):121847 [PMID: 37209896]
  33. Lancet Public Health. 2018 Mar;3(3):e124-e132 [PMID: 29475810]
  34. Front Psychiatry. 2023 Apr 11;14:1105987 [PMID: 37113536]
  35. BMC Bioinformatics. 2011 Mar 17;12:77 [PMID: 21414208]
  36. Alcohol. 2023 Mar;107:97-107 [PMID: 36150608]
  37. Front Endocrinol (Lausanne). 2023 Jan 19;13:1084656 [PMID: 36743910]
  38. Front Mol Neurosci. 2023 Mar 13;16:1123708 [PMID: 36993785]
  39. Transl Stroke Res. 2024 Feb;15(1):219-237 [PMID: 36631632]
  40. Clin Exp Med. 2023 Oct;23(6):2601-2617 [PMID: 36682001]
  41. Curr Neuropharmacol. 2021;19(8):1273-1303 [PMID: 33357195]
  42. Curr Med Chem. 2021;28(1):19-52 [PMID: 31965936]
  43. Brain Behav Immun. 2023 Mar;109:331-343 [PMID: 36791893]
  44. Essays Biochem. 2021 Dec 22;65(7):925-940 [PMID: 34623415]
  45. J Hepatol. 2022 Apr;76(4):910-920 [PMID: 34902531]
  46. Saudi J Biol Sci. 2022 May;29(5):3687-3693 [PMID: 35844400]
  47. Neurotoxicology. 2017 Jul;61:143-187 [PMID: 28363508]
  48. J Clin Invest. 2023 May 15;133(10): [PMID: 36928314]
  49. Neuron. 2003 Jul 31;39(3):409-21 [PMID: 12895417]
  50. Dig Dis. 2012;30 Suppl 1:55-60 [PMID: 23075869]
  51. Cell. 2012 May 25;149(5):1060-72 [PMID: 22632970]
  52. Prog Neuropsychopharmacol Biol Psychiatry. 2023 Aug 30;126:110777 [PMID: 37100272]
  53. Front Neurosci. 2021 Mar 23;15:620899 [PMID: 33833661]
  54. Front Neurol. 2023 May 26;14:1189746 [PMID: 37305753]

Word Cloud

Created with Highcharts 10.0.0ADalcoholdependencegenesanalysisFerroptosisimmunediseasediagnosticfunctionalshowed0Alzheimer'sstudiesrelationshipcellinteractionsFerroptosis-relatedcandidatenetworksROCmicroenvironmentFinallypredictionmodelvalueACSL4originsdemonstratedPCDdevelopmentdatasetGenerelevantrelatedconductedidentifyDEGsenrichmentusedmachinelearningcrossoverinteractionPPIANNcurvesinfiltrationconsensusclusteringusingdifferentsubgroupsmiRNA-geneidentifiedvalidationpredictivehsa-mir-34a-5phas-mir-106b-5psimultaneouslyregulateexpressionCYBBgoodAUCCIBackground:neurodegenerativewhoseuniversallyacceptedNumeroushowevercombinedprogrammeddeathanalyzemechanisticpairdiseasespreviouspsychiatricdisordersconcerningneurodegeneration-relatedfoundinterestinglinkpathwaypresentstudyexploredbioinformatictriedelucidatepredictaspectMethods:selectedGSE118553GSE44456ExpressionOmnibusGEOdatabasegatheredSetEnrichmentAnalysisGSEAKyotoEncyclopediaGenesGenomesKEGGliteratureresultingtotal88datasetsLimmadifferentiallyexpressedperformedintersectionsetFurthermoreferroptosis-relatedperformemployingLeastAbsoluteShrinkageSelectionOperatorLASSOregressionimmune-relatedcentralalsoconstructprotein-proteinartificialneuralwellplotreceiveroperatingcharacteristicdiagnosinganalyzedexploreroledysregulationSubsequentlythreegenemodelsexaminedpathwaysgeneratednetworkgene-geneNetworkanalystResults:DEGcontains278stronglycorrelatedcrossedobtainsevenThreefinallybuildplottedassessresultshighmetabolismpatientssignificantlyassociatedtargetConclusion:obtainedeffectcomprehensivedatasets7591-0608195-068groupingvariabilitymetaboliclikelycauseprognosisfunctiondiscoveredBioinformaticsbasedAlzheimer’sSTEAP3cybB

Similar Articles

Cited By